AGO2 and breast neoplasm: Further, corresponding to the increased Ago2/CAV1 interaction in metastatic breast tumors (Fig. 8A), we observed that the levels of EV miR-3613-3p in circulation increase with tumor progression into metastasis (Fig. 9H).